Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative s-ketamine for chronic postoperative pain after breast cancer surgery
ChiCTR2300070728Phase 4Not yet recruiting
- Sponsor
- Renmin Hospital, Hubei University of Medicine
- Start
- Mar 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in breast cancer and Persistent postsurgical pain (PPSP) (2 arms), sponsored by Renmin Hospital, Hubei University of Medicine. Primary endpoint: chronic postoperative pain. Planned start Mar 2023; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
breast cancerPersistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on ChiCTR2300070728.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300070728.